Petros Pharmaceuticals, Inc. financial data

Symbol
PTPI on OTC
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 69% % -51%
Quick Ratio 11% % -55%
Debt-to-equity -552% % -345%
Return On Equity 304% %
Return On Assets -67% % -291%
Operating Margin -346% % -48%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42,372,260 shares 323%
Common Stock, Shares, Outstanding 42,284,502 shares 322%
Entity Public Float $3,948,512 USD 26%
Common Stock, Value, Issued $4,228 USD 322%
Weighted Average Number of Shares Outstanding, Basic 42,284,502 shares 10654%
Weighted Average Number of Shares Outstanding, Diluted 42,284,502 shares 10654%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $5,112,043 USD -12%
Research and Development Expense $2,615,050 USD 8.5%
Operating Income (Loss) $17,880,126 USD -97%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $18,329,966 USD -11156%
Net Income (Loss) Attributable to Parent $7,023,339 USD -49%
Earnings Per Share, Basic 54 USD/shares 100%
Earnings Per Share, Diluted 54 USD/shares 100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,070,266 USD 56%
Accounts Receivable, after Allowance for Credit Loss, Current $416,076 USD -81%
Inventory, Net $1,349,802 USD -16%
Other Assets, Current $6,532 USD -94%
Assets, Current $6,133,468 USD -43%
Property, Plant and Equipment, Net $22,948 USD -21%
Operating Lease, Right-of-Use Asset $113,730 USD -50%
Intangible Assets, Net (Excluding Goodwill) $3,204,354 USD -64%
Assets $6,133,468 USD -70%
Accounts Payable, Current $421,142 USD -74%
Accrued Liabilities, Current $512,029 USD -92%
Liabilities, Current $2,765,381 USD -78%
Operating Lease, Liability, Noncurrent $75,223 USD -45%
Other Liabilities, Noncurrent $75,223 USD -45%
Liabilities $2,765,381 USD -84%
Retained Earnings (Accumulated Deficit) $110,958,270 USD -6.8%
Stockholders' Equity Attributable to Parent $3,368,087 USD 8.1%
Liabilities and Equity $6,133,468 USD -70%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,660,088 USD -46%
Net Cash Provided by (Used in) Financing Activities $8,707,002 USD
Common Stock, Shares Authorized 7,000,000,000 shares 2700%
Common Stock, Shares, Issued 42,284,502 shares 322%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,256,259 USD -104%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6,070,266 USD 90%
Deferred Tax Assets, Valuation Allowance $20,390,942 USD 13%
Operating Lease, Liability $137,656 USD -48%
Lessee, Operating Lease, Liability, to be Paid $163,433 USD -49%
Operating Lease, Liability, Current $62,433 USD -50%
Lessee, Operating Lease, Liability, to be Paid, Year Two $82,326 USD 1.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $81,107 USD -48%
Operating Lease, Weighted Average Discount Rate, Percent 0.17 pure 32%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $25,777 USD -54%
Deferred Tax Assets, Operating Loss Carryforwards $11,866,778 USD 25%
Additional Paid in Capital $114,322,129 USD 6.8%
Amortization of Intangible Assets $2,800,623 USD -14%
Depreciation, Depletion and Amortization $2,831,219 USD -14%
Share-based Payment Arrangement, Expense $197,215 USD -53%